Almac, Pfizer reveal steps to slash gene therapy labeling times 12-Feb-2020 By Nick Taylor Almac outlines work with Pfizer to quickly get patient-specific gene therapies to DMD patients.
Bayer recalls mislabeled vials of hemophilia treatment 31-Jul-2019 By Maggie Lynch Bayer recalls vials of an antihemophilic treatment after the discovery that nearly 1,000 were mislabeled with a therapy indicated for an adult patient population.